Market Overview The amyloidosis treatment market is transplanting as organ transplantation eligibility expands for select amyloidosis subtype. The Amyloidosis Treatment Market is projected to grow through 2030, driven by heart transplant outcome improvement, liver transplant for hereditary ATTR, kidney transplant for AL renal failure, and combined organ transplant supporting organ replacement...